Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for July 16th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, July 16th:

Jack in the Box Inc. (JACK - Free Report) : This operator and franchiser of Jack in the Box quick-service restaurants has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 6.6% over the last 60 days.

Jack In The Box Inc. Price and Consensus

Jack in the Box has a price-to-earnings ratio (P/E) of 21.67 compared with 22.60 for the industry. The company possesses a Value Score of B.

Jack In The Box Inc. PE Ratio (TTM)

Dynagas LNG Partners LP (DLNG - Free Report) : This provider of seaborne transportation has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 32.6% over the last 90 days.

Dynagas LNG Partners LP Price and Consensus

Dynagas has a price-to-earnings ratio (P/E) of 6.09 compared with 16.30 for the industry. The company possesses a Value Score of A.

Dynagas LNG Partners LP PE Ratio (TTM)

Washington Prime Group Inc. : This retail REIT has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 90 days.

Washington Prime Group Inc. Price and Consensus

Washington Prime has a price-to-earnings ratio (P/E) of 0.99 compared with 9.20 for the industry. The company possesses a Value Score of A.

Washington Prime Group Inc. PE Ratio (TTM)

Encore Capital Group, Inc. (ECPG - Free Report) : This specialty finance company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 2.3% over the last 90 days.

Encore Capital Group Inc Price and Consensus

Encore Capital has a price-to-earnings ratio (P/E) of 4.74 compared with 22.20 for the industry. The company possesses a Value Score of A.

Encore Capital Group Inc PE Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Find more top income stocks with some of our great premium screens.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Published in